Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 69

1.

RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.

Guo W, Wang C, Guo Y, Shen S, Guo X, Kuang G, Dong Z.

Clin Exp Metastasis. 2015 Jan;32(1):83-98. doi: 10.1007/s10585-015-9693-6. Epub 2015 Jan 13.

PMID:
25579665
2.

Decreased expression and aberrant methylation of RASSF5A correlates with malignant progression of gastric cardia adenocarcinoma.

Han L, Dong Z, Wang C, Guo Y, Shen S, Kuang G, Guo W.

Mol Carcinog. 2015 Dec;54(12):1722-33. doi: 10.1002/mc.22245. Epub 2014 Nov 24.

PMID:
25420558
3.

RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.

Zhou XH, Yang CQ, Zhang CL, Gao Y, Yuan HB, Wang C.

Oncol Rep. 2014 Oct;32(4):1505-12. doi: 10.3892/or.2014.3387. Epub 2014 Aug 7.

PMID:
25109282
4.

Expression, purification, crystallization and preliminary X-ray analysis of the human NORE1 SARAH domain.

Kim HJ, Hwang E, Han YH, Choi S, Lee WC, Kim HY, Jeon YH, Cheong C, Cheong HK.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jul 1;68(Pt 7):813-5. doi: 10.1107/S1744309112021744. Epub 2012 Jun 28.

5.

Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.

Lee CK, Lee JH, Lee MG, Jeong SI, Ha TK, Kang MJ, Ryu BK, Hwangbo Y, Shim JJ, Jang JY, Lee KY, Kim HJ, Chi SG.

BMC Cancer. 2010 Oct 22;10:577. doi: 10.1186/1471-2407-10-577.

6.

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Geli J, Kogner P, Lanner F, Natalishvili N, Juhlin C, Kiss N, Clark GJ, Ekström TJ, Farnebo F, Larsson C.

Int J Cancer. 2008 Jul 15;123(2):389-394. doi: 10.1002/ijc.23533.

7.

RASSF family proteins and Ras transformation.

Vos MD, Clark GJ.

Methods Enzymol. 2006;407:311-22.

PMID:
16757334
8.

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.

Macheiner D, Heller G, Kappel S, Bichler C, Stättner S, Ziegler B, Kandioler D, Wrba F, Schulte-Hermann R, Zöchbauer-Müller S, Grasl-Kraupp B.

J Hepatol. 2006 Jul;45(1):81-9. Epub 2006 Feb 7.

PMID:
16516329
9.

The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.

Moshnikova A, Frye J, Shay JW, Minna JD, Khokhlatchev AV.

J Biol Chem. 2006 Mar 24;281(12):8143-52. Epub 2006 Jan 18.

10.

CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.

Irimia M, Fraga MF, Sanchez-Cespedes M, Esteller M.

Oncogene. 2004 Nov 11;23(53):8695-9.

PMID:
15378027
11.

MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5.

Li TK, Yin K, Chen Z, Bao Y, Zhang SX.

Genet Mol Res. 2017 Mar 8;16(1). doi: 10.4238/gmr16019327.

PMID:
28290615
12.

Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.

Arora P, Basu A, Schmidt ML, Clark GJ, Donninger H, Nichols DB, Calvisi DF, Kaushik-Basu N.

Hepatology. 2017 May;65(5):1462-1477. doi: 10.1002/hep.29049. Epub 2017 Mar 30.

13.

Ras Regulates Rb via NORE1A.

Barnoud T, Donninger H, Clark GJ.

J Biol Chem. 2016 Feb 5;291(6):3114-23. doi: 10.1074/jbc.M115.697557. Epub 2015 Dec 16.

14.

Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.

Schmidt ML, Donninger H, Clark GJ.

J Biol Chem. 2014 Nov 7;289(45):31102-10. doi: 10.1074/jbc.M114.594283. Epub 2014 Sep 12.

15.

Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma.

Shinmura K, Tao H, Nagura K, Goto M, Matsuura S, Mochizuki T, Suzuki K, Tanahashi M, Niwa H, Ogawa H, Sugimura H.

Lung Cancer. 2011 Jan;71(1):19-27. doi: 10.1016/j.lungcan.2010.04.006.

PMID:
20434789
16.

Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.

Bee C, Moshnikova A, Mellor CD, Molloy JE, Koryakina Y, Stieglitz B, Khokhlatchev A, Herrmann C.

J Biol Chem. 2010 May 21;285(21):16258-66. doi: 10.1074/jbc.M109.081562. Epub 2010 Mar 25.

17.

Functional interaction of the Ras effector RASSF5 with the tyrosine kinase Lck: critical role in nucleocytoplasmic transport and cell cycle regulation.

Kumari G, Singhal PK, Suryaraja R, Mahalingam S.

J Mol Biol. 2010 Mar 19;397(1):89-109. doi: 10.1016/j.jmb.2010.01.005. Epub 2010 Jan 11.

PMID:
20064523
18.

NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.

Macheiner D, Gauglhofer C, Rodgarkia-Dara C, Grusch M, Brachner A, Bichler C, Kandioler D, Sutterlüty H, Mikulits W, Schulte-Hermann R, Grasl-Kraupp B.

Cancer Res. 2009 Jan 1;69(1):235-42. doi: 10.1158/0008-5472.CAN-08-2144.

19.

The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis.

Kuznetsov S, Khokhlatchev AV.

PLoS One. 2008;3(12):e3997. doi: 10.1371/journal.pone.0003997. Epub 2008 Dec 22.

20.

Induction of apoptosis by NORE1A in a manner dependent on its nuclear export.

Park SJ, Lee D, Choi CY, Ryu SY.

Biochem Biophys Res Commun. 2008 Mar 28;368(1):56-61. doi: 10.1016/j.bbrc.2008.01.044. Epub 2008 Jan 22.

PMID:
18211824

Supplemental Content

Support Center